Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN)’s stock price traded down 3.3% during mid-day trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The business has a 50-day moving average of GBX 3.88 and a 200-day moving average of GBX 3.95. The firm has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Activity at Eden Research

In other Eden Research news, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). 14.02% of the stock is owned by company insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.